Time to Significant Benefit of Finerenone in Patients With Heart Failure
Year: 2024
Type: article
Abstract: International audience
Institutions: Brigham and Women's Hospital, Harvard University, University of Glasgow, National University of Singapore, Duke-NUS Medical School, National Heart Centre Singapore, Ospedale Papa Giovanni XXIII, University of Milano-Bicocca, Northwestern University, University Medical Center Groningen, University of Groningen, Centre d'Investigation Clinique Pierre Drouin, French Clinical Research Infrastructure Network, Défaillance Cardiovasculaire Aiguë et Chronique, Université de Lorraine, University of Michigan
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $6,825
Funder: Bayer Corporation
OpenAlex ID: W4402944641
